Internationally Recognized Quality & Lab Accreditations
The 6 Pillars of Our Clinical Excellence
Over 2,500 international patients from more than 45 countries have chosen our medical network in India. This trust is built on six foundational pillars designed to eliminate medical uncertainties, guarantee cellular quality, and deliver compassionate patient care:
JCI & NABH Partner Hospitals
All therapeutic infusions and surgical procedures take place within internationally accredited tertiary hospitals in Delhi NCR, Mumbai, and Bangalore. Unlike standalone day clinics abroad, our partner facilities feature 24/7 intensive care units (ICUs), laminar airflow surgical theatres, and advanced resuscitation emergency infrastructure.
Certified cGMP Cleanrooms
Cell harvesting, isolation, and expansion occur strictly inside ISO Class 5 / Class 10,000 cleanroom environments. Every cellular batch is validated with flow cytometry for specific phenotypic cluster markers (CD34+, CD133+, CD73+, CD90+, CD105+) and guaranteed above 90% cell viability with negative endotoxin and sterility screening.
Multidisciplinary Medical Boards
No single physician decides your therapy. Each patient file undergoes rigorous collaborative evaluation by a tumor/medical board comprising senior neurologists, orthopedic surgeons, hematologists, stem cell biologists, and physical rehabilitation directors with an average of 18+ years of clinical seniority.
65% to 75% Cost Advantage
India provides access to world-class stem cell therapy at a fraction of Western clinic costs (typically $4,000 – $9,500 USD compared to $25,000 – $60,000+ USD in the USA, Panama, or Europe). We provide upfront, written, itemized package quotations with zero hidden international fees or billing surprises.
Integrated Neuro-Rehabilitation
Stem cells alone require microenvironmental activation. Our protocols synergize targeted cellular delivery with state-of-the-art neuro-rehabilitation: Hyperbaric Oxygen Therapy (HBOT), robotic-assisted gait therapy, aquatic physical therapy, occupational training, and functional electrical stimulation (FES) to maximize neurological plasticity.
VIP Concierge & 12-Month Telehealth
International patients receive full concierge assistance: Indian e-Medical Visa invitation letters within 24–48 hours, complimentary airport transfers in private sanitised vehicles, multilingual coordinators (Arabic, French, Spanish, Russian), luxury family accommodation assistance, and structured 12-month post-discharge tele-rehabilitation monitoring.
International Clinical Comparison: India vs. Other Global Hubs
When considering regenerative therapy abroad, families must evaluate more than just the price tag. Hospital accreditation, emergency readiness, laboratory testing rigor, and post-discharge continuity are critical factors:
| Clinical Parameter | India (Our Center) | United States | Mexico / Caribbean | Panama |
|---|---|---|---|---|
| Indicative Cost Range | $4,000 – $9,500 USD | $25,000 – $60,000+ | $8,000 – $18,000 | $15,000 – $32,000 |
| Hospital Accreditation | JCI & NABH Super-Specialty | JCI / State Licensed | Varies (Many Small Clinics) | Private Day Clinics |
| Lab Cleanroom Grade | ISO Class 5 / cGMP Certified | cGMP Compliant | Inconsistent Testing | Certified cGMP |
| Emergency ICU On-Site | Yes (24/7 Full ICU & OT) | Yes (In Hospital) | Rarely (Day Surgery Centers) | Rarely (Outpatient Only) |
| Cell Viability Testing | >90% (Flow Cytometry COA) | High Quality | Often Unverified | >80% Claimed |
| Ethical Framework | ICMR-DBT / IEC Oversight | FDA IND Strict Restrictions | COFEPRIS Oversight | Health Ministry Guidelines |
| International Concierge | Full VIP (Visa, Airport, Translators) | Self-Coordinated | Limited Concierge | Concierge Available |
| Post-Treatment Monitoring | 12-Month Telehealth Follow-up | Local Physician Care | Minimal Follow-up | Remote Check-in |
Our Zero-Compromise Cell Quality Assurance
Not all stem cell treatments are created equal. Therapeutic efficacy relies entirely on cellular viability, dose density, and phenotypic purity. Before any vial is approved for clinical infusion, our laboratory team conducts rigorous multi-tier testing:
Flow Cytometry Phenotyping
We identify and quantify positive surface markers (CD34+, CD133+ for hematopoietic and CD73+, CD90+, CD105+ for mesenchymal lineages) while confirming negative expression for hematopoietic markers (CD45, CD34, HLA-DR) in MSC batches to prevent immunogenic rejection.
Trypan Blue Viability Assays
Every sample is tested for membrane integrity. Only cell suspensions demonstrating greater than 90% active viability are released for clinical patient administration.
Endotoxin & Mycoplasma Sterility
Rapid automated testing screens for endotoxins, aerobic and anaerobic bacteria, fungi, and mycoplasma to eliminate any risk of infection or pyrogenic fever reaction.
Official Certificate of Analysis (COA)
Every patient receives an official laboratory Certificate of Analysis upon discharge documenting the exact total nucleated cell count (TNC), cell viability percentage, and harvest parameters.